HUMORAL IMMUNE RESPONSES TO EPSTEIN-BARR VIRUS IN PATIENTS WITH PRECANCEROUS GASTRIC LESIONS AND GASTRIC CANCER OF DIFFERENT HISTOTYPES
https://doi.org/10.21294/1814-4861-2016-15-5-40-46
Abstract
The paper presents the results of determining the concentration of specific antiviral immunoglobulins to viral antigens in blood serum of patients with gastric dysplasia (n=56) and gastric cancer (n=54), as well as the incidence of their titers depending on tumor location and histotype. In patients with precancerous gastric lesions, the increase in the IgG titer to Epstein Barr Virus (EBV) capsid antigen (VCA) and IgG to EBV early antigen (EA) in blood serum was found to be associated with enhancement of inflammatory activity. In patients with gastric cancer, high titers of IgG to VCA and IgG to EA were observed more frequently than in patients with gastric dysplasia, and the decrease in differentiation grade was followed by the increase in the concentration of IgG to EBV VCA. High titers (≥1:320) of IgG to VCA were found of patients with tumors located in the gastric body and cardia. High IgG titers to EBV VCA were shown to be associated with the presence of exophytic and ulcerated exophytic tumor growth.
About the Authors
M. V. VusikRussian Federation
MD, DSc, Leading Researcher, Endoscopic Department, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences (Tomsk, Russian Federation)
R. I. Pleshko
Russian Federation
MD, DSc, Professor of Department of Morphology and General Pathology, Siberian State Medical University (Tomsk, Russian Federation)
T. V. Avdeenko
Russian Federation
MD, PhD, Physician, Endoscopy Department, Cancer Research Institute, Tomsk National Research Medical Center the Russian Academy of Sciences (Tomsk, Russian Federation)
O. V. Cheremisina
Russian Federation
MD, DSc, Head of Endoscopy Department, Cancer Research Institute, Tomsk National Research Medical Center the Russian Academy of Sciences (Tomsk, Russian Federation)
References
1. Cancer incidence in Russia in 2010 (morbidity and mortality) / edited by V.I. Chissov, V.V. Starynsky, G.V. Pertrova. М.: P.A. Herzen Moscow Research Institute of Oncology; 2012, 260 p. [in Russian]
2. Pisareva L.F., Odintsova I.N., Ananina O.A., Afanasyev S.G., Volkov M.Yu., Davydov I.M. Gastric cancer in Tomsk region: epidemiological aspects. Siberian Journal of Oncology. 2013; 6: 40–43. [in Russian]
3. Ryan J.L., Morgan D.R., Dominguez R.D., Thorne L.B., Elmore S.H., Mino-Kenudson M., Lauwers G.Y., Booker J.K., Gulley M.L. High levels of Epstein-barr virus DNA in latently infected gastric adenocarcinoma. Lab Invest. 2009 Jan; 89 (1): 80–90. doi: 10.1038/labinvest.2008.103.
4. Schetter A.J., You W.C., Lennette E.T., Gail M.T., Rabkin C.S. Association of Epstein-Barr virus antibody levels with precancerous lesions in a high-risk cohort. Cancer Sci. 2008 Feb; 99 (2): 350–4. doi: 10.1111/j.1349-7006.2007.00668.x.
5. Stepanov I.V., Zavyalova М.V., Grigorieva Е.S., Bukurova Yu.A., Afanasyev S.G., Cerdyntseva N.V. Clinical-morphological and moleculargenetic features of intestinal and diffuse types of gastric carcinoma. Siberian Journal of Oncology. 2010; 4: 55– 66. [in Russian]
6. Avdeenko Т.V., Vusik М.V., Pleshko R.I., Yevtushenko V.A., Matveenko О.А. The role of H pylori infection and inflammation in the pathogenesis of gastric cancer. Siberian Journal of Oncology. 2011; 5: 79–86. [in Russian]
7. Gurtsevich V.E., Senyuta N.B., Kondratova V.N., Goncharova Е.V., Ignatova А.V., Lomaya М.V., Kropotov M.A., Mudunov A.M., Lihtenshtein A.V. Diagnostic value of serum of EBV DNA quantification and and antibody to viral capsid antigen in nasopharyngeal carcinoma patients from nonendemic region. Successes of molecular oncology. 2015; 2: 56–62. [in Russian]
8. Bautista-Quach M.A., Ake C.D., Chen M., Wang J. Gastrointestinal lymphomas: morphology, immunophenotype and molecular features. J Gastrointest Oncol. 2012 Sep; 3 (3): 209–25. doi: 10.3978/j.issn.2078-6891.2012.024.
9. Speck O., Tang W., Morgan D.R., Kuan P.F., Meyers M.O., Dominguez R.L., Martinez E., Gulley M.L. Three molecular subtypes of gastric adenocarcinoma have distinct histochemical features reflecting Epstein-Barr virus infection status and neuroendocrine differentiation. Appl Immunohistochem Mol Morphol. 2015 Oct; 23 (9): 633–45. doi:10.1097/PAI.0000000000000122.
10. Ma X.Q., Wang L.P., Luo Q.C., Cai J.C. Relationship between the expression level of miR-29c and biological behavior of gastric cancer. Zhonghua Zhong Liu Za Zhi. 2013 May; 35 (5): 325–30. doi: 10.3760/cma.j.issn.0253-3766.2013.05.002.
11. Vusik M.V., Pleshko R.I., Avdeenko T.V., Cheremisina O.V., Urazova L.N., Yunusova N.V. Features of inflammatory infiltrate of the gastric mucosa in patients with precancerous changes and Epstein-Barr virus-associated cancer. Siberian Journal of Oncology. 2014; 6: 33–9. [in Russian]
12. Kotelevets С.М. Morphological and functional comparisons in the development of intestinal metaplasia in the gastric mucosa. Russian Journal of gastroenterology, hepatology and coloproctology. 2007; 17 (2): 80–83. [in Russian]
13. Maev I.V., Zairatyants О.V., Kucheryavy Yu.А. Intestinal metaplasia of the gastric mucosa in the practice of gastroenterologist: modern view on the problem. Russian Journal of gastroenterology, hepatology and coloproctology. 2006; 16 (4): 38–48. [in Russian]
14. Tari A., Kitadai Y., Sumii M., Sasaki A., Tani H., Tanaka S., Chayama K. Basis of decreased risk of gastric cancer in severe atrophic gastritis with eradication of Helicobacter pylori. Dig Dis Sci. 2007 Jan; 52 (1): 232–9.
15. Kim B., Byun S.J., Kim Y.A., Kim J.E., Lee B.L., Kim W.H., Chang M.S. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas. Pathology. 2010 Jan; 42 (1): 58–65. doi: 10.3109/00313020903356392.
16. Murphy G., Pfeiffer R., Camargo M.C., Rabkin C.S. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology. 2009 Sep; 137 (3): 824–33. doi: 10.1053/j.gastro.2009.05.001.
17. Truong C.D., Feng W., Li W., Khoury T., Li Q., Alrawi S., Yu Y., Xie K., Yao J., Tan D. Characteristics of Epstein-Barr virus-associated gastric cancer: a study of 235 cases at a comprehensive cancer center in U.S.A. J Exp Clin Cancer Res. 2009 Feb 3; 28: 14. doi: 10.1186/1756-9966-28-14.
Review
For citations:
Vusik M.V., Pleshko R.I., Avdeenko T.V., Cheremisina O.V. HUMORAL IMMUNE RESPONSES TO EPSTEIN-BARR VIRUS IN PATIENTS WITH PRECANCEROUS GASTRIC LESIONS AND GASTRIC CANCER OF DIFFERENT HISTOTYPES. Siberian journal of oncology. 2016;15(5):40-46. (In Russ.) https://doi.org/10.21294/1814-4861-2016-15-5-40-46